These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11250950)

  • 1. Cytokine-activated endothelium recruits osteoclast precursors.
    McGowan NW; Walker EJ; Macpherson H; Ralston SH; Helfrich MH
    Endocrinology; 2001 Apr; 142(4):1678-81. PubMed ID: 11250950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
    Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
    J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
    J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
    van't Hof RJ; Ralston SH
    J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
    Merle B; Itzstein C; Delmas PD; Chenu C
    J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors.
    Itonaga I; Sabokbar A; Neale SD; Athanasou NA
    Biochem Biophys Res Commun; 1999 Oct; 264(2):590-5. PubMed ID: 10529407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intercellular adhesion molecule 1 discriminates functionally different populations of human osteoblasts: characteristic involvement of cell cycle regulators.
    Tanaka Y; Maruo A; Fujii K; Nomi M; Nakamura T; Eto S; Minami Y
    J Bone Miner Res; 2000 Oct; 15(10):1912-23. PubMed ID: 11028443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclast progenitors from cats with and without tooth resorption respond differently to 1,25-dihydroxyvitamin D and interleukin-6.
    Booij-Vrieling HE; de Vries TJ; Schoenmaker T; Tryfonidou MA; Penning LC; Hazewinkel HA; Everts V
    Res Vet Sci; 2012 Apr; 92(2):311-6. PubMed ID: 21497870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2003 Aug; 18(8):1404-18. PubMed ID: 12929930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.
    Lader CS; Flanagan AM
    Endocrinology; 1998 Jul; 139(7):3157-64. PubMed ID: 9645689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
    Shalhoub V; Faust J; Boyle WJ; Dunstan CR; Kelley M; Kaufman S; Scully S; Van G; Lacey DL
    J Cell Biochem; 1999 Feb; 72(2):251-61. PubMed ID: 10022507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow.
    Shibata T; Shira-Ishi A; Sato T; Masaki T; Masuda A; Hishiya A; Ishikura N; Higashi S; Uchida Y; Saito MO; Ito M; Ogata E; Watanabe K; Ikeda K
    J Bone Miner Res; 2002 Apr; 17(4):622-9. PubMed ID: 11918219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease.
    Hirayama T; Sabokbar A; Itonaga I; Watt-Smith S; Athanasou NA
    J Pathol; 2001 Dec; 195(5):624-30. PubMed ID: 11745700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells.
    Ishizuka S; Kurihara N; Miura D; Takenouchi K; Cornish J; Cundy T; Reddy SV; Roodman GD
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):331-4. PubMed ID: 15225795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-macrophage colony stimulating factor suppresses lipopolysaccharide-induced osteoclast-like cell formation in mouse bone marrow cultures.
    Shuto T; Jimi E; Kukita T; Hirata M; Koga T
    Endocrinology; 1994 Feb; 134(2):831-7. PubMed ID: 8299579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
    Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
    Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNFα inhibits the development of osteoclasts through osteoblast-derived GM-CSF.
    Atanga E; Dolder S; Dauwalder T; Wetterwald A; Hofstetter W
    Bone; 2011 Nov; 49(5):1090-100. PubMed ID: 21884837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
    Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
    J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women.
    D'Amelio P; Grimaldi A; Di Bella S; Tamone C; Brianza SZ; Ravazzoli MG; Bernabei P; Cristofaro MA; Pescarmona GP; Isaia G
    J Bone Miner Res; 2008 Mar; 23(3):373-9. PubMed ID: 17967134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.